Nathan Walcker News Today

Florida Cancer Specialists & Research Institute, LLC announced the promotion of two members of its executive and physician leadership team.

In 2023, there were 18 oncology and 7 population health Institute for Value-Based Medicine® events cohosted with organizations such as Optum, OneOncology, Vanderbilt Ingram Cancer Center, Duke Health, Cleveland Clinic, and Memorial Sloan Kettering Cancer Center.

Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.

Advocates are fighting to find solutions for a worsening cancer drug shortage, as patients fear they won't be able to get enough treatment.

/PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) announces that James A. Reeves Jr, MD will retire from its Research Division,...

/PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) has announced the promotion of three members of its Senior Management Team. Trevor...

New York, New York (PRWEB) March 01, 2022 -- Lime Connect (Lime) is pleased to announce that Nathan H. Walcker, Chief Executive Officer of Florida Cancer

Dr. Michael Diaz has been with FCS for a decade.

Florida Cancer Specialists & Research Institute Expands Care With New Location in Delray Beach December 11, 2020 16:08 ET | Source: Florida Cancer Specialists Florida Cancer Specialists Sarasota, Fort Myers, Fla., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) recently held a ribbon-cutting ceremony to celebrate the opening of a new state-of-the-art facility in Delray Beach. Located at 5130 Linton Blvd. Suit...